Trial intelligence / Profile preview

Pharmacogenetic Warfarin Dosing in Low TTR Patients

NCT02592980Phase 4Unknown

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Jan 2016
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of warfarin in Atrial fibrillation (AFib), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Status: unknown.

02

Drugs

warfarin
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT02592980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02592980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call